SCHEMBL9869901

SCHEMBL9869901

CC(Br)CC(Br)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL489803 0.83
SCHEMBL2637647 0.83
SCHEMBL489804 0.83
SCHEMBL28638484 0.82 ALDH1A1 (0.61)
SCHEMBL8308905 0.82 ALDH1A1 (0.61)
SCHEMBL27949976 0.81 ALDH1A1 (0.48)
Hydrochloric Acid SCHEMBL18580855 0.81 RNPEP (0.48)
SCHEMBL310533 0.81
SCHEMBL4955010 0.79 ALDH1A1 (0.46)
SCHEMBL27533786 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110028441-A A kind of fluoro- 2-(1- bromine cyclopropyl of 5-) pyridine synthetic method 江苏工程职业技术学院 2019-07-19 CN claimed
US-4973708-A TRANSDERMAL ENHANCER FOR PENETRATION OF DRUGS THROUGH THE SKIN UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 1990-11-27 US claimed
EP-3623372-A1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS Forma Therapeutics, Inc. (US) 2020-03-18 EP disclosed
CN-110446700-A Compound GLAXOSMITHKLINE IP DEV LTD 2019-11-12 CN disclosed
EP-3240791-B1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS FORMA THERAPEUTICS INC (US) 2019-11-06 EP disclosed
CN-110028441-A A kind of fluoro- 2-(1- bromine cyclopropyl of 5-) pyridine synthetic method 江苏工程职业技术学院 2019-07-19 CN disclosed
CN-104524590-B The purposes of crosslinking agent and they 伊缪诺金公司 2019-06-21 CN disclosed
CN-105745214-B Tricyclic piperidine compounds 埃科特莱茵药品有限公司 2019-02-19 CN disclosed
CN-105517574-B The combination product of hepatitis C virus inhibitors 百时美施贵宝公司 2019-01-18 CN disclosed
CN-104524592-B Crosslinking agent and their purposes 伊缪诺金公司 2018-06-05 CN disclosed
CN-108112251-A NRF2 conditioning agents 葛兰素史克知识产权发展有限公司 2018-06-01 CN disclosed
CN-108064223-A FXR (NR1H4) modulating compound of hydroxyl 吉利德科学公司 2018-05-22 CN disclosed
CN-107922353-A IDO inhibitor 百时美施贵宝公司 2018-04-17 CN disclosed
US-5032402-A 3-hydroxy-N-methylpyrrolidone and use as transdermal enhancer THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 1991-07-16 US disclosed
US-4973708-A TRANSDERMAL ENHANCER FOR PENETRATION OF DRUGS THROUGH THE SKIN UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 1990-11-27 US disclosed